GPVI antagonist 3 (Compound 2) is a promising antiplatelet agent that selectively inhibits the interaction between the Glycoprotein VI (GPVI) receptor and its ligands. It demonstrates potent inhibitory effects with IC50 values of 1.01 µM for collagen, 1.92 µM for CRP, 7.24 µM for convulxin, and 51.74 µM for thrombin, positioning it as a potential novel antithrombotic treatment [1].
Molecular Weight:
393.44
CAS Number:
[901654-94-2]
Formula:
C22H23N3O4
Target:
Others
T61811
* VAT and and shipping costs not included. Errors and price changes excepted
